Venus Concept (NASDAQ:VERO) Stock Price Down 0.5% – Time to Sell?
by Scott Moore · The Cerbat GemVenus Concept Inc. (NASDAQ:VERO – Get Free Report) traded down 0.5% during mid-day trading on Thursday . The stock traded as low as $1.82 and last traded at $1.84. 29,357 shares were traded during mid-day trading, a decline of 31% from the average session volume of 42,785 shares. The stock had previously closed at $1.85.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Venus Concept in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.
Check Out Our Latest Stock Analysis on VERO
Venus Concept Trading Down 0.5%
The business’s 50-day moving average price is $2.07 and its 200-day moving average price is $2.30. The firm has a market capitalization of $2.61 million, a PE ratio of -0.04 and a beta of -0.11. The company has a debt-to-equity ratio of 1.59, a current ratio of 0.90 and a quick ratio of 0.59.
Venus Concept (NASDAQ:VERO – Get Free Report) last issued its quarterly earnings results on Thursday, November 13th. The company reported ($12.14) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.61) by ($8.53). Venus Concept had a negative return on equity of 1,904.25% and a negative net margin of 92.76%.The business had revenue of $13.78 million for the quarter, compared to analyst estimates of $14.48 million.
About Venus Concept
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
Read More
- Five stocks we like better than Venus Concept
- Canada Bond Market Holiday: How to Invest and Trade
- 3 Recently Downgraded Stocks to Avoid in 2026
- Growth Stocks: What They Are, What They Are Not
- The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Oracle Stock Hit Hard: Why Its AI Pipeline Could Drive a 2026 Rally